BACKGROUND: Current understanding of metabolic heart disease consists of a myriad of different pathophysiological mechanisms. Epicardial adipose tissue (EAT) is increasingly recognized as metabolically active and associated with adverse cardiovascular outcomes. The present study aimed to investigate the effect of increased EAT volume index on left ventricular (LV) myocardial fat content and burden of interstitial myocardial fibrosis and their subsequent effects on LV myocardial contractile function.
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BACKGROUND: Current understanding of metabolic heart disease consists of a myriad of different pathophysiological mechanisms. Epicardial adipose tissue (EAT) is increasingly recognized as metabolically active and associated with adverse cardiovascular outcomes. The present study aimed to investigate the effect of increased EAT volume index on left ventricular (LV) myocardial fat content and burden of interstitial myocardial fibrosis and their subsequent effects on LV myocardial contractile function. ) and without diabetes mellitus or hypertension were prospectively recruited. EAT volume index, LV myocardial fat content, and extracellular volume were quantified by magnetic resonance imaging. LV myocardial contractile function was quantified by speckle tracking echocardiography global longitudinal strain on the same day as magnetic resonance imaging examination. Mean total EAT volume index, LV myocardial fat content, and extracellular volume were 30.0±19.6 cm 3 / m 2 , 5.06%±1.18%, and 27.5%±0.5%, respectively. On multivariable analyses, increased EAT volume index and insulin resistance were independently associated with both increased LV myocardial fat content content and higher burden of interstitial myocardial fibrosis. Furthermore, increased EAT volume index was independently associated with LV global longitudinal strain.
METHODS AND RESULTS:

T
here is a growing body of evidence that the altered metabolic milieu seen in obese and diabetic patients causes myocardial structural changes and contractile dysfunction. 1 Commonly referred to as metabolic heart disease, we have previously shown that impaired left ventricular (LV) myocardial systolic function as quantified by two-dimensional (2D) global longitudinal strain (GLS) echocardiography was associated with increased myocardial fat accumulation, coronary artery disease, increased interstitial fibrosis, and increased epicardial adipose tissue (EAT) volume. [2] [3] [4] [5] EAT is depot of visceral fat directly overlying the myocardium and is of similar embryological origin as abdominal mesenteric and omental visceral fat. 6 Increasingly, EAT is recognized as a metabolically active endocrine organ that secretes adipokines associated with detrimental myocardial and coronary vascular dysfunction. 7 Several studies have demonstrated a direct correlation between EAT and myocardial fat (ie, triglyceride [TG] ) accumulation, 8, 9 and animal research suggested that EAT may directly channel fatty acids to the myocardium as a local energy source. 10, 11 However, when the amount of free fatty acid uptake by the heart exceeds its oxidative capacity, it is converted and stored as intracellular TG. 12 It is currently accepted that the intracellular myocardial TG is probably inert, but increased shunting of free fatty acid into the nonoxidative pathway leads to accumulation of toxic fatty acid intermediates such as ceramide that disrupt normal cellular signaling and eventually leads to cellular apoptosis and replacement fibrosis. 13 Magnetic resonance imaging (MRI) techniques, such as proton magnetic resonance spectroscopy ([1H]-MRS) and multiecho Dixon water and fat separated imaging with variable projection (VARPRO), can quantify LV myocardial fat (LV-myoFat) content. 14, 15 Similarly, the modified Look-Locker inversion recovery (MOLLI) sequence can quantify the burden of interstitial fibrosis by extracellular volume (ECV) expansion. 16, 17 In the present study, volunteers of normal weight, as well as overweight and obese individuals without the confounding influences of diabetes mellitus or hypertension, were evaluated to determine the effect of increased EAT volume index on LV-myoFat content and burden of LV interstitial fibrosis. We hypothesize that (1) increased EAT volume index is independently associated with increased myocardial fat accumulation and interstitial fibrosis; and (2) EAT volume index is independently associated with myocardial contractile function.
METHODS
Study Population and Study Protocol
A total of 40 volunteers with a wide range of body mass index were prospectively recruited from the community. Exclusion criteria included age <18 years, pregnancy, rhythm other than sinus rhythm, hypertension, diabetes mellitus, previously known underlying coronary artery disease, LV systolic dysfunction or previous myocardial infarction, moderate or severe valvular stenosis or regurgitation, preexisting hepatic or renal disorders, active smoker, current use of any regular medications, inability to provide informed consent, and inability to undergo a cardiac MRI. All participants' blood tests, transthoracic echocardiogram, and cardiac MRI examinations were performed on the same day after an overnight fast. Figure 1 outlines the study protocol. In brief, a subset of 15 randomly selected volunteers underwent clinical reference standard [1H]-MRS to validate LV-myoFat content by VARPRO. All 40 volunteers underwent cardiac MRI to quantify LV volumes, LV mass, EAT volume, LV-myoFat content by the VARPRO, and burden of LV interstitial fibrosis by ECV using the MOLLI sequence. 4, 16, 17 All 40 volunteers also underwent echocardiograms to quantify myocardial contractile function by 2D LV GLS.
The study was approved by the institutional ethics committee, and all subjects provided written informed consent. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure for competitive reasons.
Demographic, Anthropomorphic, and Metabolic Data
All subjects underwent an overnight fast of at least 8 hours. Clinical data collected included age, sex, height, weight, waist/hip ratio, and resting blood pressures. Waist circumference was measured midway between the lower rib margin and iliac crest. Hip circumference was measured at the level of widest circumference over greater trochanters. 18 Blood tests included fasting lipid profile, fasting plasma glucose, glycated hemoglobin (hemoglobin A1c), insulin, and glomerular filtration rates calculated by the Modification of Diet in Renal Disease formula. 
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CLINICAL PERSPECTIVE
Cardiac MRI
All participants underwent a cardiac MRI examination using a 1.5T Siemens Magnetom Avanto (Erlangen, Germany) system on the same day as their transthoracic echocardiogram and blood tests. During the examination, the entire heart was imaged in the short-axis orientation with retrospective ECG gating and breath-hold. Typical imaging parameters were as follows: balanced steady-state free-precession imaging, echo time (TE)=1.0 ms, repetition time (TR)=3.1 ms, flip angle=54°, slice thickness=8 mm with a gap of 2 mm, field of view=340×340 mm, reconstructed matrix size=156×192.
LV end-diastolic mass index, LV end-diastolic volume index, and LV end-systolic volume index were measured and corrected for body surface area. 21 LV ejection fraction was calculated and expressed as a percentage. Differences in LV end-diastolic and end-systolic volumes were used to calculate stroke volume, multiplied by heart rate to calculate cardiac output, and corrected for body surface area to calculate cardiac index. Peripheral vascular resistance was calculated as the ratio of mean blood pressure to cardiac output. Images were digitally stored on hard disks and analyzed offline using dedicated quantitative software (MASS V2010-EXP, Leiden University Medical Center, Leiden, The Netherlands).
MRI Quantification of Myocardial TG/Fat Content
Quantification of myocardial TG content by [1H]-MRS is considered the clinical reference standard but is time consuming to perform (mean scan duration, 13.2±4.5 minutes). 13, 22 In contrast, newer MRI techniques, such as VARPRO, can rapidly obtain fat and water separated images to quantify LV-myoFat content in a single breath-hold. Furthermore, it can avoid contamination from EAT. Therefore, a subset of 15 volunteers underwent concomitant [1H]-MRS to validate LV-myoFat by VARPRO.
Quantification of Myocardial TG Content by [1H]-MRS
Cardiac [1H]-MRS was performed as previously described (Figure 2 , top). 2, 22 Briefly, [1H]-MRS spectra were obtained by point resolved spectroscopy sequence with a 6 mL voxel (1×2×3 cm) placed in the interventricular septum using the 4-chamber and short-axis views at end diastole. Spectroscopic data acquisitions were double-triggered with ECG triggering and respiratory navigator echoes to minimize motion artifacts. End-diastolic spectra were acquired with the following parameters: TE=25 ms, TR=2000 ms, 1024 data points, bandwidth 1000 Hz. Automatic shimming was performed before the spectroscopy data acquisition using the gradient-recalled echo shim technique, whereby a field map was generated from a single-slab double-echo 3-dimensional gradient-recalled echo acquisition with 2 in-phase TEs with respect to fat and water, which were then used to calculate the shim currents to improve B0 homogeneity. Watersuppressed spectra were acquired with 128 signal averages to quantify myocardial TG. Nonwater suppressed spectra were acquired with 16 signal averages and used as an internal standard.
[1H]-MRS data were then fitted by use of Java-based MR user interface software (jMRUI version 2.2, Leuven, Belgium) AMARES algorithm as previously described. 2 Resonance frequency estimates for myocardial TG were described by assuming Gaussian line shapes and summing Resonance frequency estimate for water used for internal standardization was described by assuming a Lorentzian line shape that peaks at 4.7 ppm. Myocardial TG content relative to water was calculated and expressed as a percentage based on (signal amplitude of myocardial TG)/(signal amplitude of water)×100%.
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Quantification of LV-MyoFat Content by VARPRO Sequence
The VARPRO multipoint Dixon algorithm is a multiecho gradient sequence with fat and water separation. 14, 23, 24 This multiecho Dixon fat-water separation jointly estimates the fieldmap, fat, and water images (Figure 2 , middle). The sequence was ECG triggered, with 2 R-R intervals between Myocardial TG was calculated from the summation of the lipid resonance amplitudes at 0.9 and 1.3 ppm (top right). Quantification of left ventricular (LV) myocardial fat by variable projection (VARPRO), where epicardial and endocardial borders were deliberately drawn in the midmyocardium to avoid contamination from epicardial adipose tissue (EAT) and LV blood pool (middle). The water only (middle left) and fat only (middle right) were obtained simultaneously from VARPRO, and both the endocardial and epicardial contours were identical on both images. Example of quantification of EAT volume (bottom).
inversions, and used an echo-train readout with 4 echoes. Typical imaging parameters were as follows: gradient echo, TE=1.27, 3.18, 5.09, 7.00 ms, TR=11.2 ms, flip angle=24°, slice thickness 6 mm, field of view=360×292 mm, reconstructed matrix size=256×218, bandwidth=1502 Hz/ pixel. The LV basal and midventricular short-axis slices by the VARPRO sequence were obtained at exactly the same LV level as quantification of interstitial fibrosis by MOLLI sequence (see below).
During analysis, the LV contours at the basal and midventricular short-axis slices were deliberately drawn in the midmyocardium to exclude and avoid contamination by EAT and the LV blood pool using MASS research software. Although the LV apical segments were also acquired during the VARPRO image acquisitions, it was not included in the analyses because of partial volume effects from EAT and LV blood pool secondary to the curvature of the LV apex that will compromise accurate quantifications of LV-myoFat content. LV-myoFat fat content was calculated and expressed as a percentage based on (mean pixel signal intensity of LV fat-only image)/(mean pixel signal intensity of LV water-only image)×100%.
MRI Quantification of LV Interstitial Fibrosis by MOLLI Sequence
The MOLLI T1 mapping sequence was used to quantify the burden of interstitial fibrosis by ECV. 16, 17 All participants received 0.1 mmol/kg of gadolinium diethylenetriamine penta-acetic acid. The MOLLI sequence imaging parameters were as follows: single-shot steady-state free precession read out with trigger delay to coincide with end diastole, TE=1.0 ms, TR=2.7 ms, flip angle=35°, slice thickness=8 mm, field of view=340×340 mm, reconstructed matrix size=106×192 pixels, trigger delay=300 ms. The LV basal and midventricular short-axis slices by the MOLLI sequence were obtained at exactly the same LV level as quantification of LV-myoFat content by VARPRO. These images were then processed with a curve fitting technique to generate T1 maps as described below.
To quantify the ECV, LV endocardial and epicardial borders were outlined using MASS research software. 4, 25 Contours were deliberately drawn to ensure the inclusion of only myocardium and the exclusion of EAT and LV blood pool. The software then performs automatic pixel-by-pixel quantification of myocardial T1 time by fitting data acquired at the various inversion times. 4, 25 A mean global native and postcontrast myocardial T1 time were subsequently automatically calculated as the average of all the individual myocardial T1 time from each pixel. ECV was calculated as per previous publication and expressed as a percentage 
MRI Quantification of EAT Volume
Total EAT volume was quantified using a T1-weighted double inversion recovery Half-Fourier-Acquired Single-shot Turbo spin Echo black blood imaging (Figure 2, bottom) . Manual contours were drawn, whereby mediastinal fat and pericardial fat (outside the visceral pericardium and on the external surface of the parietal pericardium) were excluded. The volumes of EAT in all the slices were calculated by converting the number of pixels to square centimetres multiplied by the slice thickness. Total EAT volume was subsequently calculated by summing the volumes of all slices from the level of pulmonary artery bifurcation to the diaphragm and indexed to body surface area. Typical imaging parameters were as follows: turbo spin echo, TE=26.0 ms, TR=1000 ms depending on RR interval, flip angle=160°, slice thickness 6 mm with a gap of 6 mm, field of view=440×440 mm, reconstructed matrix size=256×176.
MRI Quantification of Visceral Adiposity
Abdominal visceral fat depots were quantified by using the VARPRO sequence with similar imaging parameters as outlined previously. Six consecutive transverse images were obtained with the middle image at the middle of the fourth lumbar vertebra. Similarly, manual contours were drawn to include only the abdominal visceral fat, and the volumes of the visceral fat depots in each slice was calculated by converting the number of pixels to square centimeters multiplied by the slice thickness. The total L4 visceral fat volume was calculated by summing the volumes of all 6 slices.
Echocardiography
Transthoracic echocardiography was performed with the subjects at rest using a commercially available ultrasound system (Vivid E9, 4V probe, GE-Vingmed, Horten, Norway) on the same day as their cardiac MRI and blood tests. A complete 2D, color, pulsed, and continuous-wave Doppler echocardiogram was performed according to standard techniques. 26 All images were digitally stored on hard disks for offline analysis (EchoPAC version 113, GE-Vingmed, Horten, Norway).
Doppler Assessment
Mitral inflow velocities were recorded using conventional pulsed-wave Doppler echocardiography in the apical 4-chamber view using a 2-mm sample volume. Transmitral early (E wave) and late (A wave) diastolic velocities as well as deceleration time were recorded at the mitral leaflet tips. Pulsed-wave tissue Doppler velocities were recorded at the septal mitral annulus in the apical 4-chamber view at end-expiration as recommended to obtain the mitral annular early diastolic (e′) velocity. 27 LV filling pressure (septal E/e′) was calculated as the ratio of transmitral E wave to septal mitral annular e′ velocity.
Two-Dimensional Speckle Tracking
The 2D speckle tracking analyses were performed on standard gray scale images in the apical 2-, 3-, and 4-chamber views. During analysis, the endocardial border was manually traced at end systole and the region of interest width adjusted to include the entire myocardium. LV GLS was calculated from the 3 individual apical GLS curves.
Statistical Analysis
All continuous variables were tested for Gaussian distribution. Continuous variables were presented as mean±1 SD unless otherwise stated, and categorical variables were presented as frequencies and percentages. Unpaired Student t test and Mann-Whitney U test were used to compare 2 groups of continuous variables of Gaussian and non-Gaussian distribution, respectively. Pearson correlation was used to determine the association between 2 continuous variables. Intraclass correlation and Bland-Altman plot were used to validate VARPRO to quantify LV-myoFat content against clinical reference standard myocardial TG content by [1H]-MRS. Multiple linear regression analyses were performed to identify independent variables associated with LV-myoFat content by VARPRO sequence, ECV as a measure of LV interstitial fibrosis, and 2D LV GLS by speckle tracking echocardiography. In each multiple linear regression model, significant univariables with P<0.05 were entered as covariates, and independent variables were identified using the backward elimination method. To avoid potential multicollinearity, a tolerance of >0.4 (equating to a variance inflation factor of >2.5) was set. To determine if EAT volume index was independently associated with LV-myoFat, ECV, and 2D LV GLS (rather than just a measure of overall visceral adiposity), all multivariable analyses were repeated with L4 visceral fat volume forced into the models. A 2-tailed P<0.05 was considered significant. All statistical analyses were performed using IBM SPSS Statistics for Windows, version 21.0 (Armonk, NY).
RESULTS
A total of 40 volunteers (26 men) with a mean age of 35±10 years were recruited. The mean heart rate, LV end-diastolic volume index, LV end-systolic volume index, LV ejection fraction, and LV mass index were 61±9 beats/min, 90±15 mL/m 
Validation of VARPRO Sequence Against [1H]-MRS
A subset of 15 randomly volunteers underwent clinical reference standard [1H]-MRS to quantify myocardial TG content. Table 1 outlines the baseline clinical, MRI, and echocardiographic characteristics between the 15 randomly selected volunteers against the rest of the cohort. Other than a slight difference in ECV between these 2 groups (27.3%±0.5% versus 27.8%±0.4%; P=0.037), there were no significant differences in other variables. Figures 3 and 4 
Determinants of LV-MyoFat Content
The mean LV-myoFat content by VARPRO for all 40 volunteers was 5.06%±1.18%. There was no sex difference in LV-myoFat content (P=0.36). LV-myoFat content increased with older age (r=0. To identify the independent variables associated with LV-myoFat content, significant univariables (age, HOMA-IR, EAT volume index, waist/hip ratio, plasma TG, LDL cholesterol, and HDL cholesterol) were entered as covariates into a multiple linear regression model. On multivariable analysis, only HOMA-IR (standardized β=0.32; P=0.024) and EAT volume index (standardized β=0.47; P=0.002) were independently associated with LV-myoFat content.
To determine whether increased EAT volume index was truly independently associated with LV-myoFat content rather than just a measure of overall visceral adiposity, waist/hip ratio was replaced with L4 visceral fat volume in the multiple linear regression model. Although L4 visceral fat volume was highly correlated with EAT volume index (r=0.69; P<0.001), it was forced into the multivariable model. Despite that, similar results were obtained with only HOMA-IR (standardized β=0.32; P=0.024) and EAT volume index (standardized β=0.47; P=0.002) remaining as significantly associated with LV-myoFat content.
Determinants of Burden of LV Interstitial Fibrosis
The mean ECV was 27.5%±0.5%, and there was no sex difference (P=0.88). On univariable analysis, ECV was significantly correlated with higher LV-myoFat content (r=0.71; P<0.001), older age (r=0.64; P=0.002), higher HOMA-IR (r=0.51; P=0.021), and increasing EAT volume index (r=0.69; P=0.001).
To identify the independent variables associated with ECV, significant univariables (age, LV-myoFat, HOMA-IR, and EAT volume index) were entered as covariates into a multiple linear regression model. EAT volume index (standardized β=0.46; P=0.025) and LV-myoFat content (standardized β=0.41; P=0.045) were indepen- 2D indicates 2-dimensional; BP, blood pressure; EAT, epicardial adipose tissue; ECV, extracellular volume; EDVI, end-diastolic volume index; EF, ejection fraction; ESVI, end-systolic volume index; GFR, glomerular filtration rate; GLS, global longitudinal strain; [1H]-MRS, proton magnetic resonance spectroscopy; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment index of insulin resistance; LDL, low-density lipoprotein; LV, left ventricular; LV-myoFat, left ventricular myocardial fat content by variable projection sequence; and MRI, magnetic resonance imaging.
*P value by unpaired Student t test or Mann-Whitney U test for continuous variables of Gaussian and non-Gaussian distribution, respectively, and χ 2 test for categorical variables.
dently associated with ECV. The results did not change when L4 visceral fat volume was forced into the multivariable model.
Determinants of LV Myocardial Function
The mean 2D LV GLS was −19.0%±2.4%, and women had significantly higher GLS than men (−20. 
001).
On multivariable analysis whereby age, sex, HOMA-IR, EAT volume index, LV-myoFat, and ECV were entered into the model, only EAT volume index was independently associated with 2D LV GLS (standardized β=0.44; P=0.041). Similarly, when L4 visceral fat volume was forced into the model, only EAT volume index remained independently associated with 2D LV GLS.
Variability Analysis
We have previously reported the intra-and interobserver measurement variabilities for LV GLS expressed as mean absolute difference±1 SD were 1.2%±0.5% and 0.9%±1.0%, respectively.
28 Table 2 outlines the intra-and interobserver measurement variabilities for ECV, LV-myoFat content, and EAT volume index expressed as mean absolute differences±1 SD and intraclass correlation for agreement in 10 randomly selected subjects.
DISCUSSION
The present study evaluated the complex interplay between insulin resistance, increased EAT volume, myocardial fat accumulation, and LV interstitial fibrosis, leading to LV myocardial systolic dysfunction in volunteers with normal weight, as well as overweight and obese individuals. This study showed that insulin resistance and EAT volume index were independently associated with increased myocardial fat accumulation and LV interstitial fibrosis. On multivariable analyses, EAT volume index was independently associated with impaired LV myocardial systolic contractile function.
Quantification of LV-MyoFat by VARPRO Versus [1H]-MRS
In the present study, VARPRO significantly overestimated LV-myoFat content compared with [1H]-MRS. This is likely secondary to its inherent T1 bias, especially with its high flip angle. As previously shown by Kühn et al 29 and Liu et al, 30 increasing flip angle (≥5°-10°) will overestimate fat fraction by chemical shift imaging compared with [1H]-MRS. However, a lower flip angle will significantly reduce the signal-to-noise ratio, and the noise can lead to incorrect estimation of the true fat fraction. 30 Although VARPRO significantly overestimated LV-myoFat content, it still had excellent correlation and reliability when compared with [1H]-MRS ( Figure 3) .
However, VARPRO has significant advantages over [1H]-MRS. First, it permits regional and global LV quantification of LV-myoFat, whereas [1H]-MRS is limited to the interventricular septum because of the risk of contamination from EAT. Second, VARPRO is performed with a single breath-hold, whereas [1H]-MRS will require double respiratory and cardiac gating that will significantly increase scan duration. 22 Finally, slice 
Epicardial Adipose Tissue, Insulin Resistance, and Myocardial Steatosis
The myocardium has a high energy demand to perform cardiac contraction and relaxation. Under normal physiological conditions, it predominately metabolizes free fatty acids through β-oxidation which accounts for ≈50% to 70% of its energy production. 7 Although the source of this free fatty acid is generally derived from circulating plasma TG and free fatty acid, it is now recognized that EAT is a readily available local store of TG that directly release free fatty acid to the myocardium at times of increased cardiac fatty acid metabolism. 10, 11, 31 As such, the present study demonstrated that both increased EAT volume index and insulin resistance were independently associated with increased myocardial fat accumulation. This is consistent with previous studies that showed increased EAT volume in obese patients was associated with increased myocardial fat accumulation. 8, 9 In addition, type 2 diabetes mellitus, the archetypal disease where pathophysiology is characterized by insulin resistance, is also associated with increased myocardial fat accumulation.
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Epicardial Adipose Tissue and Myocardial Interstitial Fibrosis
However, EAT is also now increasingly recognized as an endocrine organ that secretes adipokines. 7 Both EAT and the underlying myocardium share the same coronary microcirculation with no anatomic fascial boundary separating the 2 structures. As such, adipokines and cytokines secreted by EAT have a direct vasocrine and paracrine effect on coronary and myocardial function. 32 Secretions of proinflammatory adipokines such as interleukin-6, monocyte chemoattractant protein-1, leptin, and visfatin are increased with larger EAT volumes while the secretions of anti-inflammatory adipokines such as adiponectin and adrenomedullin are decreased, all leading to increased coronary vasoconstriction, inflammation, and atherosclerosis. 7 Furthermore, increased secretion of TNF-α (tumor necrosis factor-α) from EAT has also been shown to induce cardiomyocyte apoptosis leading to replacement fibrosis. 33 Mazurek et al 33 previously demonstrated higher levels of proinflammatory cytokines, such as interleukin-6 and TNF-α in EAT harvested from patients undergoing coronary artery bypass grafting compared with subcutaneous adipose tissue. TNF-α worsens insulin resistance and causes vasoconstriction, which is also associated with increased production of angiotensin II and endothelin-1. 34, 35 Previous studies have shown that increased TNF-α is associated with cardiac dilatation, increased interstitial inflammatory infiltrates, abnormal calcium homeostasis, increased apoptosis, extracellular matrix remodeling, ventricular arrhythmias, and death. 36, 37 To the best of the authors' knowledge, the present in vivo study is the first to demonstrate larger EAT volumes is associated with increased myocardial interstitial fibrosis in humans.
Epicardial Adipose Tissue and Myocardial Contractility
In vitro studies of EAT derived from guinea pigs fed a high-fat diet 38 and diabetic patients undergoing coronary bypass surgery 39 showed that unlike subcutaneous adipose tissue, EAT have altered secretory profiles that directly contribute to cardiomyocyte contractile dysfunction. Mediated through adipokines including activin A and angiopoietin-2, they adversely affect cytosolic Ca 2+ metabolism and reduce sarcomere shortening in a dose-dependent manner. 38, 39 We have previously shown increased EAT volume was associated with myocardial systolic contractile dysfunction. 5 The present study extends these findings by showing that the observed myocardial contractile dysfunction often seen in obese and diabetic patients is likely secondary to functional (ie, direct cardio-depressant effects of adipokines) and structural changes (ie, increased myocardial interstitial fibrosis from inflammation secondary to adipokines) in the myocardium mediated by an increased EAT volume. 
Clinical Implications
The present findings suggest that EAT is a marker of visceral adiposity with direct adverse effects on myocardial structure and function. Therefore, it may be a target for pharmacological therapy and serve as a prognostic indicator. Previous small studies using hydroxymethyl glutaryl-CoA reductase inhibitors (ie, statins), 40 dipeptidyl peptidase 4 inhibitors (eg, sitagliptin), 41 and glucagon-like peptide-1 (eg, liraglutide) 42 have been shown to reduce EAT volume. The effects of EAT volume reduction on myocardial structural and functional changes need to be assessed in future studies.
Study Limitations
Although the present study provides new and novel findings on myocardial structural and functional changes associated with EAT, the study only recruited volunteers of varying body mass index but without diabetes mellitus or hypertension. This was to avoid potential confounding influences of diabetes mellitus and hypertension on myocardial interstitial fibrosis and altered myocardial contractile function. Therefore, the present results serve as a pilot for future studies in diabetic patients. Second, although the present study demonstrated significant independent associations between increased EAT volume index, increased LV-myoFat, increased interstitial fibrosis, and LV myocardial contractile dysfunction, it does not equate to causality in humans despite various published in vitro basic science, as well as animal studies.
Conclusions
The current findings demonstrate that increased EAT was associated with LV myocardial fat accumulation and increased interstitial fibrosis. Both increased EAT and increased interstitial fibrosis were independently associated with myocardial contractile function. Therefore, therapeutic interventions targeting EAT may serve to modulate the detrimental effects of metabolic heart disease.
